Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11137 - 11144 of 11616 results
Monday Morning Privacy 101
November 7, 2011| Blog| Viewpoint
Guidance for Biotech/Life Sciences Companies on Avoiding Litigation with Contract Partners
November 1, 2011| Blog| Viewpoint
Staffing Company Ordered to Pay Back Wages to H-1B Employees
November 1, 2011| Blog| Viewpoint
Sunrise Period Ends on October 28th for .XXX Domains
October 26, 2011| Blog| Viewpoint
SEC Guidance to Public Companies: Evaluate and Disclose Cybersecurity Risks
October 20, 2011| Blog| Viewpoint
Cyberbullying
October 19, 2011| Blog| Viewpoint
17 U.S.C. Sec. 505 Means What It Says: Attorney's Fees Award to Prevailing Party Discretionary
October 18, 2011| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.